Close
Nordic 9Nordic 9

Kinarus (private company)

Switzerland kinarus.com
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechPharma
Business model:B2B

Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 20.93M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Kinarus

Name Criteria
Finland Aurealis Pharma
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Desentum
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden iCellate
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Nanoform Finland
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Oncomatryx
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
France Owkin
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Switzerland Pharvaris
47%
  • Similar verticals: Biotech, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top